NCT06736548

Brief Summary

This single-arm research study of off-treatment cancer survivors with self-reported symptoms of insomnia will test the Sleep Treatment Education Program Together (STEP-Together) intervention which is delivered as a synchronous group session by videoconference.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable

Timeline
7mo left

Started Jun 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress57%
Jun 2025Dec 2026

First Submitted

Initial submission to the registry

December 12, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

December 16, 2024

Completed
6 months until next milestone

Study Start

First participant enrolled

June 25, 2025

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Last Updated

July 2, 2025

Status Verified

July 1, 2025

Enrollment Period

1.4 years

First QC Date

December 12, 2024

Last Update Submit

July 1, 2025

Conditions

Keywords

InsomniaChronic InsomniaCancer Survivorship

Outcome Measures

Primary Outcomes (1)

  • Change in Insomnia Severity Index (ISI) Score from Baseline to 8 weeks Post-Intervention

    Assessed by the Insomnia Severity Index, a 7-item measure measuring insomnia over the previous two weeks with answers graded on a 5-point Likert scale, ranging from 0 "No Problem" to "4 "Very Severe" for a total score range of 0 to 28. A higher score reflects moderate to severe insomnia symptoms.

    Baseline to 8 weeks post-intervention

Secondary Outcomes (3)

  • Change in Total Mood Disturbance (TMD) Scale from the Profile of Mood States - Short Form (POMS-SF) Score from Baseline to 8 weeks Post-Intervention

    Baseline to 8 weeks post-intervention

  • Change in Perceived Cognitive impairment Scale from Baseline to 8 weeks Post-Intervention

    Baseline to 8 weeks post-intervention

  • Change in Impact of Cognitive Function on Quality of Life Scale from Baseline to 8 weeks Post-Intervention

    Baseline to 8 weeks post-intervention

Study Arms (1)

STEP-Together Intervention

EXPERIMENTAL

Enrolled participants will complete the educational intervention session (STEP-Together) delivered by an interventionist during an online group videoconference session. -Up to 12 participants will also take part in a coaching session 1 week after the virtual intervention session.

Behavioral: The Sleep Treatment Education Program Together (STEP-Together)Behavioral: Coaching Session

Interventions

STEP-Together is delivered in a single videoconference group session delivered live by a presenter. During the session, the participants are able to see and hear the presenter, view the presentation slides, and ask questions. The presentation includes educational information on the problem of insomnia after cancer and specific suggestions for improving sleep. Suggestions are presented in four sections addressing lifestyle issues, sleep environment, sleep timing, and managing expectations and challenges. During the course of the session, participants are asked to use these suggestions to develop an individual sleep action plan they will use to improve their sleep.

Also known as: STEP-Together
STEP-Together Intervention

Coaching sessions are brief (\<1hour) sessions intended to support participants in implementing their personal sleep self-management plan. In the session, participants are asked to review their progress with their plan, report on areas of sucess and difficulty with adoption, and to problem solve with the study team as needed to support their sucessful implementation their plan.

STEP-Together Intervention

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18-89
  • History of a cancer diagnosis (except non-melanoma skin cancer) ≥ 6 months prior
  • No active cancer therapy (excluding chemoprevention) in the past four months, and no further therapy planned.
  • Significant insomnia as evidenced by an Insomnia Severity Index score ≥ 8
  • Regular access to the internet
  • Able to read and write in English

You may not qualify if:

  • Usual bedtime does not fall between 5:00 pm and 5:00 am.
  • Employment in a position where falling asleep at work could impact public safety (such as air traffic-controller, operating heavy machinery).
  • Ever diagnosed with Bipolar Disorder or with Seizure Disorder, currently taking medications to prevent a seizure, or have experienced a seizure in the prior 12 months.
  • Any impairment (e.g., hearing, visual, cognitive) that interferes with the ability to complete all study procedures independently.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Dana Farber Cancer Institute

Boston, Massachusetts, 02115, United States

RECRUITING

MeSH Terms

Conditions

Sleep Initiation and Maintenance Disorders

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Officials

  • Christopher Recklitis, PhD, MPH

    Dana-Farber Cancer Institute

    PRINCIPAL INVESTIGATOR

Central Study Contacts

STEP-Together Coordinator

CONTACT

Cheryl Medeiros-Nancarrow

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Single Group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 12, 2024

First Posted

December 16, 2024

Study Start

June 25, 2025

Primary Completion (Estimated)

October 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

July 2, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will share

The Dana-Farber / Harvard Cancer Center encourages and supports the responsible and ethical sharing of data from clinical trials. De-identified participant data from the final research dataset used in the published manuscript may only be shared under the terms of a Data Use Agreement. Requests may be directed to: \[contact information for Sponsor Investigator or designee\]. The protocol and statistical analysis plan will be made available on Clinicaltrials.gov only as required by federal regulation or as a condition of awards and agreements supporting the research.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
Data can be shared no earlier than 1 year following the date of publication
Access Criteria
Contact the Belfer Office for Dana-Farber Innovations (BODFI) at innovation@dfci.harvard.edu

Locations